EP1819326
DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.11.2005EP published:
2.7.2014EP application number:
05826219.7
EPO information:
European Patent Register
Max expiry date:
27.11.2025
Title:
DOSAGE REGIMEN OF AN S1P RECEPTOR AGONIST
Timeline
Today
28.11.2005EP application
2.7.2014EP Publication
Owner
Name:
Novartis AGAddress:
Corporate Intellectual Property Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
KOVARIK, John, M.Address:
Basel, CH
Name:
APPEL-DINGEMANSE, SilkeAddress:
Allschwil, CH
Priority
Number:
631483 PDate:
29.11.2004Country:
US
Classification
Categories:
A61K 31/135, A61P 37/06, A61K 31/397